Actinic Keratosis- Red Light Photodynamic Research Study-Coming Soon (Spring 2024)

We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.


  • Open-label, Ameluz® with red light photodynamic therapy (PDT) in the treatment of actinic keratosis (AK) on the face and/or scalp
  • Expanded field directed treatment
  • Mild to severe AK with at least 8 clinically confirmed mild to moderate lesions with a diameter of ≥ 4 mm on the face and/or scalp
  • 18 years and older
  • Single treatment
  • No history of peanut or soy allergy
  • 5 visits total

If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.

Volunteer for this study!

  • This field is for validation purposes and should be left unchanged.